NO20063662L - Benzimidazolderivater - Google Patents

Benzimidazolderivater

Info

Publication number: NO20063662L
Authority: NO; Norway
Prior art keywords: benzimidazole; compounds; compound; formula; preparation
Prior art date: 2004-01-14

Application number

NO20063662A

Other languages

English (en)

Norwegian (no)

Inventor

Marc Gerspacher

Sven Weiler

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-14

Filing date

2006-08-14

Publication date

2006-10-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31726170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063662(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-08-14 Application filed by Novartis Ag filed Critical Novartis Ag

2006-10-12 Publication of NO20063662L publication Critical patent/NO20063662L/no

Links

HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
150000002148 esters Chemical class 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Obesity (AREA)
Dermatology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20063662A 2004-01-14 2006-08-14 Benzimidazolderivater NO20063662L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0400781.1A GB0400781D0 (en)	2004-01-14	2004-01-14	Organic compounds
PCT/EP2005/000291 WO2005068433A1 (fr)	2004-01-14	2005-01-13	Derives benzimidazole

Publications (1)

Publication Number	Publication Date
NO20063662L true NO20063662L (no)	2006-10-12

Family

ID=31726170

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063662A NO20063662L (no)	2004-01-14	2006-08-14	Benzimidazolderivater

Country Status (22)

Country	Link
US (1)	US8030497B2 (fr)
EP (1)	EP1709006A1 (fr)
JP (1)	JP4531062B2 (fr)
KR (1)	KR100796398B1 (fr)
CN (2)	CN102199144A (fr)
AR (1)	AR049861A1 (fr)
AU (1)	AU2005205141B2 (fr)
BR (1)	BRPI0506889A (fr)
CA (1)	CA2552403A1 (fr)
CO (1)	CO5700773A2 (fr)
EC (1)	ECSP066693A (fr)
GB (1)	GB0400781D0 (fr)
IL (1)	IL176630A0 (fr)
MA (1)	MA28291A1 (fr)
NO (1)	NO20063662L (fr)
NZ (1)	NZ548319A (fr)
PE (1)	PE20050762A1 (fr)
RU (1)	RU2361863C2 (fr)
SG (1)	SG149831A1 (fr)
TN (1)	TNSN06220A1 (fr)
TW (1)	TW200539877A (fr)
WO (1)	WO2005068433A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0606426D0 (en) *	2006-03-30	2006-05-10	Novartis Ag	Benzimidazole derivatives
WO2009129625A1 (fr) *	2008-04-22	2009-10-29	Merck Frosst Canada Ltd.	Nouveaux composés hétéroaromatiques substitués en tant qu’inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase
US8765676B2 (en)	2009-05-27	2014-07-01	Leo Pharma A/S	Calcium sensing receptor modulating compounds and pharmaceutical use thereof
EP2435400A2 (fr)	2009-05-27	2012-04-04	Leo Pharma A/S	Composés inédits modulant les récepteurs du calcium et leur utilisation pharmaceutique
WO2012069420A2 (fr)	2010-11-26	2012-05-31	Leo Pharma A/S	Composés actifs sur le récepteur sensible au calcium
EP2643292A1 (fr)	2010-11-26	2013-10-02	Leo Pharma A/S	Composés actifs sur les récepteurs du calcium
JP2014508103A (ja)	2010-11-26	2014-04-03	レオファーマアクティーゼルスカブ	カルシウム感知受容体活性化合物
JP2014500882A (ja)	2010-11-26	2014-01-16	レオファーマアクティーゼルスカブ	カルシウム感知受容体活性化合物
SG11201406818VA (en) *	2012-04-23	2014-11-27	Genentech Inc	Intermediates and processes for preparing compounds
EA027113B1 (ru) *	2012-05-04	2017-06-30	Новартис Аг	Регуляторы пути комплемента и их применение
WO2018151810A1 (fr) *	2017-02-17	2018-08-23	The Scripps Research Institute	Définition de paysages d'affinité à petites molécules d'arn permettant la conception d'un petit inhibiteur moléculaire d'un arn non codant oncogène
CN107903177A (zh) *	2017-12-04	2018-04-13	武汉药明康德新药开发有限公司	4‑甲氧基‑2,3‑二硝基苯甲腈的制备方法
CN109320503B (zh) *	2018-12-10	2022-07-01	怀化学院	苯并咪唑炔胺类化合物的无金属一锅合成方法
CN110508325B (zh) *	2019-09-09	2022-04-05	鲁东大学	镍铁氢化酶模型物、离子型镍铁氢化酶模型物及制备方法和应用
CN118900840A (zh) *	2022-02-18	2024-11-05	英矽智能科技知识产权有限公司	膜相关的酪氨酸和苏氨酸特异性cdc2抑制激酶(pkmyt1)抑制剂及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR998985A (fr) *	1948-11-09	1952-01-24
US3080282A (en) *	1960-04-14	1963-03-05	Merck & Co Inc	Anthelmintic benzimidazole compositions and methods of using same
GB962533A (en) *	1962-04-24	1964-07-01	Imp Chemical Industi Australia	Anthelmintic compositions
DE1447733B2 (de) *	1963-12-23	1977-04-21	Hoechst Ag, 6000 Frankfurt	2-(3,5-dihydroxyphenyl)-benzimidazolderivate
NZ234564A (en) *	1986-11-21	1991-04-26	Haessle Ab	1-substituted benzimidazoles and pharmaceutical compositions
JPH0751293B2 (ja) *	1989-09-13	1995-06-05	三ツ星ベルト株式会社	固体充てん材を含む複合材料の成形方法
ES2094694B1 (es) *	1995-02-01	1997-12-16	Esteve Quimica Sa	Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
WO1998006703A1 (fr) *	1996-08-14	1998-02-19	Warner-Lambert Company	Derives 2-phenyle benzimidazole en tant qu'antagonistes de mcp-1
TW453999B (en) *	1997-06-27	2001-09-11	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
DE19920936A1 (de) *	1999-05-07	2000-11-09	Basf Ag	Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
US6855714B2 (en) *	2001-07-06	2005-02-15	Schering Aktiengesellschaft	1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
US20040170689A1 (en) *	2001-11-09	2004-09-02	Odink Debra Alida	Stabilized formulations comprising hydrolytically unstable compositions
US6908935B2 (en) *	2002-05-23	2005-06-21	Amgen Inc.	Calcium receptor modulating agents
US7176322B2 (en) *	2002-05-23	2007-02-13	Amgen Inc.	Calcium receptor modulating agents

2004
- 2004-01-14 GB GBGB0400781.1A patent/GB0400781D0/en not_active Ceased
2005
- 2005-01-12 AR ARP050100099A patent/AR049861A1/es not_active Application Discontinuation
- 2005-01-12 PE PE2005000058A patent/PE20050762A1/es not_active Application Discontinuation
- 2005-01-13 CN CN2011100629607A patent/CN102199144A/zh active Pending
- 2005-01-13 CN CNA2005800081741A patent/CN1930133A/zh active Pending
- 2005-01-13 NZ NZ548319A patent/NZ548319A/en unknown
- 2005-01-13 KR KR1020067014148A patent/KR100796398B1/ko not_active Expired - Fee Related
- 2005-01-13 BR BRPI0506889-4A patent/BRPI0506889A/pt not_active IP Right Cessation
- 2005-01-13 AU AU2005205141A patent/AU2005205141B2/en not_active Ceased
- 2005-01-13 SG SG200900257-7A patent/SG149831A1/en unknown
- 2005-01-13 TW TW094101020A patent/TW200539877A/zh unknown
- 2005-01-13 EP EP05700898A patent/EP1709006A1/fr not_active Withdrawn
- 2005-01-13 RU RU2006129348/04A patent/RU2361863C2/ru not_active IP Right Cessation
- 2005-01-13 WO PCT/EP2005/000291 patent/WO2005068433A1/fr not_active Ceased
- 2005-01-13 JP JP2006548267A patent/JP4531062B2/ja not_active Expired - Fee Related
- 2005-01-13 CA CA002552403A patent/CA2552403A1/fr not_active Abandoned
- 2005-01-13 US US10/585,480 patent/US8030497B2/en not_active Expired - Fee Related
2006
- 2006-06-29 IL IL176630A patent/IL176630A0/en unknown
- 2006-07-10 MA MA29180A patent/MA28291A1/fr unknown
- 2006-07-11 EC EC2006006693A patent/ECSP066693A/es unknown
- 2006-07-13 TN TNP2006000220A patent/TNSN06220A1/en unknown
- 2006-07-14 CO CO06068712A patent/CO5700773A2/es not_active Application Discontinuation
- 2006-08-14 NO NO20063662A patent/NO20063662L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2005205141B2 (en)	2008-12-11
SG149831A1 (en)	2009-02-27
IL176630A0 (en)	2006-10-31
CA2552403A1 (fr)	2005-07-28
US8030497B2 (en)	2011-10-04
CN102199144A (zh)	2011-09-28
WO2005068433A9 (fr)	2005-09-15
RU2361863C2 (ru)	2009-07-20
EP1709006A1 (fr)	2006-10-11
GB0400781D0 (en)	2004-02-18
WO2005068433A1 (fr)	2005-07-28
BRPI0506889A (pt)	2007-06-12
CO5700773A2 (es)	2006-11-30
AR049861A1 (es)	2006-09-13
AU2005205141A1 (en)	2005-07-28
PE20050762A1 (es)	2005-11-24
TNSN06220A1 (en)	2007-12-03
NZ548319A (en)	2010-05-28
JP4531062B2 (ja)	2010-08-25
KR20060113993A (ko)	2006-11-03
TW200539877A (en)	2005-12-16
US20090170921A1 (en)	2009-07-02
JP2007520477A (ja)	2007-07-26
RU2006129348A (ru)	2008-02-20
KR100796398B1 (ko)	2008-01-21
MA28291A1 (fr)	2006-11-01
CN1930133A (zh)	2007-03-14
ECSP066693A (es)	2006-10-31

Legal Events

Date	Code	Title	Description
2012-08-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20064077L (no)	2006-11-10	Kemokinreseptorantagonister
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
NO20063662L (no)	2006-10-12	Benzimidazolderivater
NO20070458L (no)	2007-01-24	Aryl-pyridinderivater som 11-Beta-HSD1 inhibitorer
NO20072515L (no)	2007-06-28	2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
HRP20041211B1 (hr)	2013-06-30	Topikalno primjenjivi farmaceutski pripravak
NO20090443L (no)	2009-03-27	2-metylmorfolin pyrido-, pyrazo- and pyrimido-pyrimidin derivater
MA31685B1 (fr)	2010-09-01	Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
NO20082389L (no)	2008-08-18	2,3,4-trifenylimidazolinderivater som inhibitor av interaksjonen mellom P53- og MDM2-proteiner for anvendelse som antikreftmidler
CY1111481T1 (el)	2015-08-05	Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
NO20080865L (no)	2008-04-18	Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20092033L (no)	2009-08-06	Nye forbindelser
CR6682A (es)	2004-01-14	Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
WO2008108386A1 (fr)	2008-09-12	Composition pharmaceutique
EP1642880A4 (fr)	2006-11-15	Inhibiteur de proteines de la famille hsp90
NO20052683L (no)	2005-06-03	Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
ATE386012T1 (de)	2008-03-15	Phenyloxyalkansäure-derivate als hppar aktivatore
NO20052074L (no)	2005-06-01	Substituerte benzoksazinoner og anvendelser derav.
NO20060147L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
WO2007092157A9 (fr)	2009-01-22	7-[1h-imidazol-4-yl) methyl]-5,6,7,8-tetrahydroquinoline
PA8579301A1 (es)	2004-05-26	Derivados de tiazol
NO20060146L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
EP1813270A4 (fr)	2009-07-01	Inhibiteurs des proteines de la famille hsp90
EA200700997A1 (ru)	2007-12-28	2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
EP1837329A4 (fr)	2009-08-05	Nouveau derive d'heteroaryle